Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Cent Nerv Syst Dis ; 9: 1179573517694529, 2017.
Article in English | MEDLINE | ID: mdl-28469524

ABSTRACT

BACKGROUND: Research into the pathophysiology of bipolar disorder (BD) is limited by the inability to examine brain cellular processes in subjects with the illness. METHODS: Endoscopic biopsy was performed in subjects with bipolar I disorder to establish olfactory neural progenitor (ONP) cell lines. Olfactory function was assessed prebiopsy and postbiopsy using the University of Pennsylvania Smell Identification Test (UPSIT). Cells were characterized to determine their lineage. RESULTS: There were no significant complications associated with the biopsy procedure, including olfaction. Outpatient olfactory neuroepithelial biopsy yielded ONP cells in three out of 13 biopsy attempts (23.1%). ONPs were positive for neuron-specific proteins (ß-tubulin III, nestin, hexaribonucleotide binding protein-3, and peripherin) and glia-specific proteins (glial fibrillary acidic protein and myelin basic protein). CONCLUSIONS: ONP cells can be obtained safely from awake outpatients and are potentially useful for pathophysiological studies of bipolar illness and perhaps other neuropsychiatric conditions. Such cells allow for the investigation of potential pathological cellular processes without the confounding factors of genetic manipulation, which is required for induced pluripotent cells.

2.
World Neurosurg ; 98: 870.e5-870.e10, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28003168

ABSTRACT

BACKGROUND: Complete surgical resection of an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma is the gold standard of treatment of Cushing disease. Ectopic location of these adenomas is an extremely rare condition that may compromise the diagnosis and surgical success. We present the first case of an ectopic intracavernous ACTH-secreting macroadenoma totally resected with endoscopic endonasal surgery (EES). CASE DESCRIPTION: A 36-year-old woman presented with Cushing syndrome. Increased ACTH, serum cortisol, and free urine cortisol levels were identified; however, pituitary magnetic resonance imaging failed to show a pituitary tumor; instead, a parasellar lesion in the left cavernous sinus (CS) was noticed. Inferior petrosal sinus sampling showed a significant central to peripheral and lateralized left-sided ACTH gradient. The patient underwent EES. No tumor was found in the sella; however, the left CS was widely explored and a tumor was found lateral to the paraclival segment of the carotid artery. There were no complications after EES. Pathology confirmed the diagnosis of an ACTH-secreting adenoma. During the immediate postoperative course, serum cortisol levels decreased lower than 5 µg/dL. Postoperative magnetic resonance imaging showed complete tumor resection. At 20 months follow-up, the patient remained in clinical and biochemical remission of Cushing disease. CONCLUSIONS: Only 12 cases of ectopic intracavernous ACTH-secreting adenomas have been reported and all were microadenomas. The presence of an ectopic ACTH-secreting macroadenoma in the CS represents a surgical challenge. EES is the ideal approach for complete resection of ectopic intracavernous adenomas, allowing for a wide exploration of the CS with no surgical complications.


Subject(s)
ACTH-Secreting Pituitary Adenoma/complications , Adenoma/complications , Cushing Syndrome/surgery , Natural Orifice Endoscopic Surgery/methods , Neurosurgical Procedures/methods , ACTH-Secreting Pituitary Adenoma/surgery , Adenoma/surgery , Adult , Cushing Syndrome/etiology , Humans , Magnetic Resonance Imaging , Male , Remission Induction
3.
Psychiatry Res ; 178(2): 391-4, 2010 Jul 30.
Article in English | MEDLINE | ID: mdl-20472302

ABSTRACT

Low levels of brain-derived neurotrophic factor (BDNF) peptide are linked to the pathophysiology of mood disorders. Several single-nucleotide polymorphisms (SNPs) across the BDNF gene (BDNF) have been associated with bipolar illness. Since both elevated intracellular sodium and apoptosis are believed to contribute to cellular dysfunction in bipolar disorder, it is important to determine the effect of exogenous BDNF on apoptosis induced by the high levels of intracellular sodium seen in ill bipolar patients. Human olfactory neuroepithelial progenitor cells were treated with monensin, a sodium ionophore that increases intracellular sodium and leads to apoptosis. Apoptosis was quantified with enzyme-linked immunosorbent assay (ELISA) for mono- and oligonucleosomes. Elevation of intracellular sodium concentration by monensin induced apoptosis. BDNF 100ng/mL pretreatment or co-treatment attenuated the monensin-induced apoptosis. Pretreatment with BDNF for 24h reduced monensin-induced apoptosis by 93%. Co-treatment of BDNF and monensin increased intracellular sodium concentration and reduced apoptosis by 66%. Monensin for 24h models a process that is believed to occur during ill phases of bipolar illness. Treatment with BDNF greatly attenuates or prevents monensin-induced apoptosis. The functional consequences of BDNF SNPs, known to be associated with bipolar illness, need to be examined.


Subject(s)
Apoptosis/drug effects , Brain-Derived Neurotrophic Factor/pharmacology , Neuroepithelial Cells/drug effects , Olfactory Bulb/cytology , Stem Cells/drug effects , Analysis of Variance , Cells, Cultured , Dose-Response Relationship, Drug , Drug Interactions , Enzyme-Linked Immunosorbent Assay/methods , Humans , Ionophores/pharmacology , Monensin/pharmacology , Time Factors
4.
Am J Gastroenterol ; 101(9): 1972-8; quiz 2169, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16968502

ABSTRACT

OBJECTIVES: Results of randomized treatment trials for laryngopharyngeal reflux (LPR) are mixed. The cause and effect between gastroesophageal reflux and laryngeal symptoms remain elusive. AIMS: To determine the efficacy of single-dose pantoprazole in newly diagnosed LPR and to correlate hypopharyngeal reflux with symptom improvement. METHODS: Randomized, double-blind, placebo-controlled trial was performed with a 2-wk run-in, 12-wk treatment period (pantoprazole 40 mg q.a.m. or placebo), and 4-wk follow-up. Study criteria were laryngeal complaints >3 days/wk and a positive triple-sensor pH test. Laryngeal exam was graded using a reflux finding score before and after treatment. Repeat pH test was performed on study drug at week 12. Weekly diaries were kept on symptom severity and global assessment. Total laryngeal symptom score was defined as the sum of six laryngeal symptoms. Mann-Whitney U, Wilcoxon, and Pearson tests were used. RESULTS: Thirty-nine subjects (13 M/26 F, median age 39 yr) were randomized; 35 completed the study. During the treatment period, total laryngeal symptom scores significantly improved compared with pretreatment scores in both study groups, but there were no significant differences between them. Forty percent of pantoprazole group reported adequate relief at week 12, compared with 42% of placebo group (p= 0.89). No significant improvement in hypopharyngeal reflux was found in either study group. There were no significant correlations between laryngeal reflux finding scores and hypopharyngeal reflux episodes with symptom improvement. CONCLUSIONS: Response was similar between single-dose pantoprazole and placebo in newly diagnosed LPR. Our results suggested that laryngeal exam was not useful in following treatment response. Hypopharyngeal reflux may represent acid reflux or artifacts, but is not likely the underlying cause.


Subject(s)
Anti-Ulcer Agents/administration & dosage , Benzimidazoles/administration & dosage , Gastroesophageal Reflux/drug therapy , Omeprazole/analogs & derivatives , Proton Pump Inhibitors , Sulfoxides/administration & dosage , 2-Pyridinylmethylsulfinylbenzimidazoles , Adult , Anti-Ulcer Agents/therapeutic use , Benzimidazoles/therapeutic use , Dose-Response Relationship, Drug , Double-Blind Method , Esophageal pH Monitoring , Esophagus/metabolism , Esophagus/physiopathology , Female , Follow-Up Studies , Gastroesophageal Reflux/metabolism , Gastroesophageal Reflux/physiopathology , Humans , Male , Manometry , Middle Aged , Omeprazole/administration & dosage , Omeprazole/therapeutic use , Pantoprazole , Pressure , Sulfoxides/therapeutic use , Time Factors , Treatment Outcome
5.
Brain Res ; 1073-1074: 109-19, 2006 Feb 16.
Article in English | MEDLINE | ID: mdl-16455065

ABSTRACT

Neurosphere forming cells (NSFCs) have been established from cultures of adult olfactory neuroepithelium obtained from patients and cadavers as described previously. They remained undifferentiated in serum or defined media with or without neurotrophic factors. Many factors affect the differentiation of stem cells along a neuronal pathway. Retinoic acid (RA), forskolin (FN), and sonic hedgehog (Shh) have been reported to act as growth promoters during neurogenesis of embryonic CNS in vivo. The effect of RA, FN, and Shh on NSFCs' neuronal lineage restriction has not been described. The application of RA, FN, and Shh to NSFCs induced the expression of motoneuronal transcription factors, tyrosine hydroxylase, an indicator of dopamine production, and neurite formation. These studies further heighten the potential for using olfactory neuroepithelial progenitors for future autologous cell replacement strategies in neurodegenerative conditions and trauma as well as for use in diagnostic evaluation.


Subject(s)
Cell Differentiation/physiology , Neurons/physiology , Olfactory Mucosa/cytology , Stem Cells/physiology , Adult , Aged, 80 and over , Analysis of Variance , Animals , Cell Differentiation/drug effects , Cells, Cultured , Chick Embryo , Choline O-Acetyltransferase/metabolism , Coculture Techniques/methods , Colforsin/pharmacology , Drug Interactions , Female , Gene Expression Regulation, Developmental/drug effects , Hedgehog Proteins , Humans , Indoles , Male , Muscle Cells/physiology , Neurites/drug effects , Neurites/physiology , Neurites/ultrastructure , Neurons/drug effects , Neurons/ultrastructure , Phosphopyruvate Hydratase/metabolism , Stem Cells/drug effects , Synapsins/metabolism , Tetrazolium Salts , Thiazoles , Trans-Activators/pharmacology , Transcription Factors/metabolism , Tretinoin/pharmacology , Tyrosine 3-Monooxygenase/metabolism , Vesicular Acetylcholine Transport Proteins/metabolism
6.
Stem Cells ; 24(2): 434-42, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16141360

ABSTRACT

Neurosphereforming cell (NSFC) lines have been established from cultures of human adult olfactory neuroepithelium. Few of these cells ever express mature neuronal or glial markers in minimal essential medium supplemented with 10% fetal bovine serum or defined medium. However, these neural progenitors have the potential to differentiate along glial or neuronal lineages. To evaluate the potential of NSFCs to form motoneurons, transcription factors Olig2, Ngn2, and HB9 were introduced into NSFCs to determine if their expression is sufficient for motoneuron specification and differentiation, as has been shown in the early development of the avian and murine central nervous systems in vivo. NSFCs transfected with Olig2, Ngn2, and HB9 alone exhibited no phenotypic lineage restriction. In contrast, simultaneous transfection of Ngn2 and HB9 cDNA increased the expression of Isl1/2, a motoneuron marker, when the cells were maintained in medium supplemented with retinoic acid, forskolin, and sonic hedgehog. Furthermore, a population of Olig2-expressing NSFCs also expressed Ngn2. Cotransfection of NSFCs with Olig2 and HB9, but not Olig2 and Ngn2, increased Isl1/2 expression. Coculture of NSFCs trans-fected with Ngn2-HB92 or Olig2 and HB9 with purified chicken skeletal muscle demonstrated frequent contacts that resembled neuromuscular junctions. These studies demonstrate that transcription factors governing the early development of chick and mouse motoneuron formation are able to drive human adult olfactory neuroepithelial progenitors to differentiate into motoneurons in vitro. Our long-term goal is to develop cell populations for future studies of the therapeutic utility of these olfactory-derived NSFCs for autologous cell replacement strategies for central nervous system trauma and neurodegenerative diseases.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/physiology , Cell Differentiation , Motor Neurons/physiology , Nerve Tissue Proteins/physiology , Olfactory Nerve/cytology , Stem Cells/physiology , Transcription Factors/physiology , Adult , Aged, 80 and over , Animals , Basic Helix-Loop-Helix Transcription Factors/metabolism , Cells, Cultured , Chickens , Coculture Techniques , Female , Homeodomain Proteins/metabolism , Homeodomain Proteins/physiology , Humans , Muscle, Skeletal/cytology , Nerve Tissue Proteins/metabolism , Oligodendrocyte Transcription Factor 2 , Phenotype , Transcription Factors/metabolism , Transfection
7.
Am J Rhinol ; 19(1): 83-90, 2005.
Article in English | MEDLINE | ID: mdl-15794081

ABSTRACT

BACKGROUND: The adult central nervous system contains progenitor cells; however, invasive surgery is required for their harvest. Olfactory neuroepithelium (ONe) has attracted attention because it is extracranial and contains progenitor cells that account for its regenerative capacity. Olfactory progenitor cells have been cultured from postmortem ONe. Our aim was to determine if olfactory progenitors could be obtained via biopsy from patients in a feasible, effective, and safe manner. METHODS: Endoscopic biopsy was performed on individuals undergoing sinus surgery (n = 42). Olfactory function was assessed pre- and postoperatively. Specimens were cultured under conditions for olfactory progenitor cell development. RESULTS: Progenitor cells emerged in cultures from 50% of our patients. The superior turbinate, biopsied with cutting punch forceps, gave the highest yield. No adverse impact on olfaction or complications with the biopsy were observed. CONCLUSION: Endoscopic biopsy of ONe for obtaining olfactory progenitor cells from living donors is feasible, effective, and safe.


Subject(s)
Biopsy/methods , Endoscopy , Olfactory Receptor Neurons , Stem Cells , Tissue and Organ Harvesting , Adolescent , Adult , Cells, Cultured , Female , Humans , Male , Microscopy, Electron, Transmission , Middle Aged , Olfactory Receptor Neurons/ultrastructure , Reproducibility of Results
8.
Laryngoscope ; 115(1): 89-92, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15630373

ABSTRACT

OBJECTIVE/HYPOTHESIS: Adding a hypopharyngeal sensor to esophageal pH monitoring has been advocated for laryngopharyngeal reflux (LPR). However, selecting the proper pH catheter is problematic because esophageal lengths are variable among individuals. OBJECTIVE: To design and implement a new pH monitoring protocol for LPR. STUDY DESIGN/METHODS: Design parameters were defined prospectively: single-probe, triple-sensor pH catheter with sensors located in the hypopharynx (1-3 cm above upper esophageal sphincter) and in proximal and distal esophagus (20 cm and 5 cm above lower esophageal sphincter, respectively). Esophageal lengths were determined in a study population undergoing esophageal manometry. Optimal pH sensor spacings were determined using the least number of catheters to satisfy the design parameters. The protocol was implemented in consecutive subjects with suspected LPR. RESULTS: Distribution of esophageal lengths was determined in 1,043 subjects. In 92% of the study population, three pH catheters (3-15, 6-15, and 9-15 sensor-spacings) would satisfy the design criteria. Forty-one subjects with suspected LPR underwent the pH protocol. An abnormal pH test was found in 40 subjects (98%) with triple-sensor combination compared with 29 subjects (71%) if only dual esophageal sensors were used. CONCLUSIONS: Single-probe pH monitoring of the hypopharynx and esophagus was feasible. Adding a hypopharyngeal pH sensor increased the detection of abnormal acid reflux more often than traditional dual-sensor esophageal pH monitoring.


Subject(s)
Gastroesophageal Reflux/diagnosis , Laryngeal Diseases/diagnosis , Monitoring, Ambulatory/instrumentation , Catheterization , Equipment Design , Female , Gastroesophageal Reflux/metabolism , Humans , Hydrogen-Ion Concentration , Laryngeal Diseases/metabolism , Male , Middle Aged , Monitoring, Ambulatory/methods
9.
Prim Care ; 30(1): 137-54, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12825253

ABSTRACT

Rhinosinusitis is one of the most common health care complaints in this country. The burden on affected individuals in terms of decreased productivity, absenteeism from the workplace, and diminished quality of life, when added to the cost of care and the growing public health menace of antibiotic-resistant bacteria, makes rhinosinusitis a serious disease that warrants precise diagnosis and effective therapy. Technologic innovations in endoscopy and imaging have improved understanding of sinus pathophysiology, but diagnosis remains clinical and treatment empiric. Recognized pitfalls in acute rhinosinusitis management are injudicious use of antibiotics and antihistamines. Chronic rhinosinusitis is a complex, multifactorial disorder, not simply an infectious disease. In many patients, noninfectious inflammation and structural problems play an important role. Medical management should include an intranasal corticosteroid in addition to an appropriate antibiotic. Otolaryngology referral is indicated for complications of acute infection, immunocompromised patients, nasal polyps, and chronic rhinosinusitis having substantial effect on quality of life. Modern surgical principles that focus on obstructive pathology in the OMC region are efficacious but rarely curative. Developments in the fields of immunology, molecular biology, and genetics will lead to more effective treatment options.


Subject(s)
Rhinitis , Sinusitis , Acute Disease , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Chronic Disease , Cost of Illness , Evidence-Based Medicine , Family Practice/standards , Humans , Nasal Decongestants/therapeutic use , Rhinitis/diagnosis , Rhinitis/drug therapy , Rhinitis/physiopathology , Sinusitis/diagnosis , Sinusitis/drug therapy , Sinusitis/physiopathology , Steroids , United States
10.
Dig Dis Sci ; 47(11): 2579-85, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12452398

ABSTRACT

Hypopharyngeal pH artifacts have been a concern in the detection of laryngopharyngeal reflux. Our purpose was to analyze and quantify artifacts from dual-sensor hypopharyngeal pH monitoring. In all, 42 hypopharyngeal and 58 esophageal pH studies were reviewed. Type 1 (out of range), type 2 (pH drift), and type 3 (isolated pH drop) artifacts were identified. The proportion of proximal-sensor pH drop to <4 that was artifactual was determined. The median number (range) of artifacts was 1 (0-17) and 2 (0-28) for hypopharyngeal and esophageal pH studies, respectively (P = NS). The median proportion of artifactual pH drop to <4 was 1% (0-84%) and 2% (0-74%) for hypopharyngeal and esophageal pH studies, respectively (P = NS). The diagnosis did not change in any patient after excluding pH artifacts. In all, 19% of the combined 2,432 hypopharyngeal pH drops of <4 were artifacts. In conclusion, hypopharyngeal pH artifacts per study were uncommon but can be prominent in a few patients. One can identify these artifacts and exclude them from analysis.


Subject(s)
Artifacts , Hypopharynx , Pharyngeal Diseases/diagnosis , Humans , Hydrogen-Ion Concentration , Monitoring, Ambulatory , Retrospective Studies
11.
Am J Rhinol ; 16(6): 343-50, 2002.
Article in English | MEDLINE | ID: mdl-12512910

ABSTRACT

BACKGROUND: Previous reports on the human vomeronasal organ (VNO) have been inconsistent. Observations of fossae on the nasal septum have been reported as the VNO. METHODS: Adult human subjects (210) and cadavers (31) were examined using rigid nasal endoscopy, serial histology, and biopsy ultrastructure (5). RESULTS: The nasopalatine fossa (NPF) and the nasopalatine recess (NPR) are discrete, but variable, structures located adjacent to the VNO region. The NPF is not a vomeronasal pit. A septal mucosal pit could hide the vomeronasal duct opening. The VNO is a submucosal structure located 2-8 mm superior to the NPR and cannot be positively identified either macroscopically or endoscopically. CONCLUSION: The VNO has long been mistaken for the NPF and septal mucosal pits. We show that serial histology is the correct method for identifying the VNO.


Subject(s)
Vomeronasal Organ/anatomy & histology , Chemoreceptor Cells/anatomy & histology , Endoscopy/methods , Histocytochemistry , Humans , Microscopy, Electron , Nasal Cavity/anatomy & histology , Nasal Mucosa/anatomy & histology , Nasal Septum/anatomy & histology , Nasal Septum/ultrastructure , Olfactory Pathways/anatomy & histology , Palate, Hard/anatomy & histology , Vomeronasal Organ/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...